Kathryn A. Roecklein

Kathryn A. Roecklein

Auto-generated profile, based on publicly available information

Kathryn A. Roecklein

University of Pittsburgh

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
KRKathryn A. Roecklein
Kathryn A. Roecklein
PWPatricia M. Wong
Patricia M. Wong
MMMegan A. Miller
Megan A. Miller
Shannon Diane DonofryShannon Diane Donofry
Shannon Diane Donofry
MKMarissa L. Kamarck
Marissa L. Kamarck
GBGeorge C. Brainard
George C. Brainard

1 September 2016 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
Shannon Diane DonofryShannon Diane Donofry
Shannon Diane Donofry
KRKathryn A. Roecklein
Kathryn A. Roecklein
JWJennifer E. Wildes
Jennifer E. Wildes
MMMegan A. Miller
Megan A. Miller
KEKirk I. Erickson
Kirk I. Erickson

10 August 2012 in Chronobiology International
Verified
Journal Article
Closed access
PDF file
KRKathryn A. Roecklein
Kathryn A. Roecklein
PWPatricia M. Wong
Patricia M. Wong
PFPeter L. Franzen
Peter L. Franzen
BHBrant P. Hasler
Brant P. Hasler
WWW. Michael Wood-Vasey
W. Michael Wood-Vasey
SMStephen B. Manuck
Stephen B. Manuck
The human melanopsin gene has been reported to mediate risk for seasonal affective disorder (SAD), which is hypothesized to be caused by decreased photic input during winter when light levels fall below threshold, resulting in differences in circadian phase and/or sleep. However, it is unclear if melanopsin increases risk of SAD by causing differences in sleep or circadian phase, or if those differences are symptoms of the mood disorder. To determine if melanopsin sequence variations are associated with differences in sleep-wake behavior among those not suffering from a mood disorder, the authors tested associations between melanopsin gene polymorphisms and self-reported sleep timing (sleep onset and wake time) in a community sample (N = 234) of non-Hispanic Caucasian participants (age 30–54 yrs) with no history of psychological, neurological, or sleep disorders. The authors also tested the effect of melanopsin variations on differences in preferred sleep and activity timing (i.e., chronotype), which may reflect differences in circadian phase, sleep homeostasis, or both. Daylength on the day of assessment was measured and included in analyses. DNA samples were genotyped for melanopsin gene polymorphisms using fluorescence polarization. P10L genotype interacted with daylength to predict self-reported sleep onset (interaction p < .05). Specifically, sleep onset among those with the TT genotype was later in the day when individuals were assessed on longer days and earlier in the day on shorter days, whereas individuals in the other genotype groups (i.e., CC and CT) did not show this interaction effect. P10L genotype also interacted in an analogous way with daylength to predict self-reported morningness (interaction p < .05). These results suggest that the P10L TT genotype interacts with daylength to predispose individuals to vary in sleep onset and chronotype as a function of daylength, whereas other genotypes at P10L do not seem to have effects that vary by daylength. A better understanding of how melanopsin confers heightened responsivity to daylength may improve our understanding of a broad range of behavioral responses to light (i.e., circadian, sleep, mood) as well as the etiology of disorders with seasonal patterns of recurrence or exacerbation. (Author correspondence: kroeck@pitt. edu )

26 August 2019 in Current Opinion in Psychology
Verified
Journal Article
Closed access
DWDelainey L Wescott
Delainey L Wescott
ASAdriane M Soehner
Adriane M Soehner
KRKathryn A Roecklein
Kathryn A Roecklein

26 March 2010 in Behavioral Sleep Medicine
Verified
Journal Article
Closed access
KRKathryn A. Roecklein
Kathryn A. Roecklein
JSJulie A. Schumacher
Julie A. Schumacher
JGJeanne M. Gabriele
Jeanne M. Gabriele
CFColleen Fagan
Colleen Fagan
ABAlp Sinan Baran
Alp Sinan Baran
ARAllen C. Richert
Allen C. Richert
Obstructive sleep apnea (OSA) is effectively treated with continuous positive airway pressure (CPAP). Low rates of CPAP adherence led to the development of a personalized feedback in- tervention requiring minimal provider burden. In a comparison of the intervention to standard information, group differences failed to reach significance. Explanations for the findings include low power, that machines were not provided, and an atypical sample. Effect sizes were medium to large at 2 weeks, suggesting that sufficiently powered studies may be warranted. © Taylor & Francis Group, LLC

2 May 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
KRKathryn A. Roecklein
Kathryn A. Roecklein
PFPeter L. Franzen
Peter L. Franzen
DWDelainey L. Wescott
Delainey L. Wescott
BHBrant P. Hasler
Brant P. Hasler
MMMegan A. Miller
Megan A. Miller
PGPaul D. Gamlin
Paul D. Gamlin